Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
July 15, 2010
Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
Asuragen, Life Tech launch BCR/ABL1 Quant test in Europe; Palex Medical to distribute Molecular Detection’s MRSA assay in Spain; Meridian Biosciences gets FDA nod for C. difficile molecular amplification assay.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Dx Focus: Roche Cobas p 630; Abbott Plex-ID System; Trio of New C. Diff Tests; MDI's MRSA Panel
April 5, 2012 / PCR Insider - Eldan to Distribute MDI's MRSA Test in Israel, Palestinian Territories
July 20, 2011 / PCR Insider - Quidel Submits First Test for FDA Approval, CE Marking as MDx Strategy Takes Shape
August 4, 2011 / PCR Insider - Molecular Detection Gets USPTO OK for MRSA/MSSA MDx Patent
July 14, 2011 / PCR Insider - FDA Clears Roche’s PCR-Based MRSA Nasal Test
July 15, 2010 / PCR Insider